Reverse transcriptase viral load correlates with RNA in SIV/SHIV-infected macaques

AIDS Research and Human Retroviruses

Volumn 22, Issue 9, 2006, Pages 917-923

  Corrigan, Gary E ^a,b,c   Hansson, Eva Olausson ^a   Mörner, Andreas ^a   Berry, Neil ^d   Källander, Clas F R ^c,e   Thorstensson, Rigmor ^a  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Cavidi Tech AB   (Sweden)

^d NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^e Cavidi AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; RNA DIRECTED DNA POLYMERASE; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL LABORATORY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; MACACA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION; VIRUS LOAD;

ANIMALS; FEMALE; LENTIVIRUS; MACACA; REAGENT KITS, DIAGNOSTIC; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; RNA-DIRECTED DNA POLYMERASE; SENSITIVITY AND SPECIFICITY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL LOAD;

EID: 33751061204     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.22.917     Document Type: Article

References (24)

1. Reyes RA, Canfield DR, Esser U, et al.: Induction of simian AIDS in infant rhesus macaques infected with CCR5- or CXCR4-utilizing simian-human immunodeficiency viruses is associated with distinct lesions of the thymus. J Virol 2004;78:2121-2130.
2. Haga T, Shimizu Y, Okoba M, et al.: Construction and in vitro properties of chimeric simian and human immunodeficiency virus with the human TNF-alpha gene. Microbiol Immunol 2002;46:849-855.
3. Weed MR, Steward DJ: Neuropsychopathology in the SIV/macaque model of AIDS. Front Biosci 2005;10:710-727.
4. Hill LR, Nehete PN, Schapiro SJ, Nehete BP, Sastry KJ: SHIV transmission and susceptibility to re-exposure through social contact following vaccination with an HIV synthetic peptide-cocktail: a case study. J Med Primatol 2004;33:10-15.
5. Daniel MD, Desrosiers RC, Letvin NL, et al.: Simian models for AIDS. Cancer Detect Prev Suppl 1987;1:501-507.
6. Palca J: A reliable animal model for AIDS. Science 1990;248:1078.
7. Kaur A, Grant RM, Means RE, McClure H, Feinberg M, Johnson RP: Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques. J Virol 1998;72:9597-9611.
8. Obaro SK, Losikoff P, Harwell J, Pugatch D: Failure of serial human immunodeficiency virus type 1 DNA polymerase chain reactions to identify human immunodeficiency virus type 1 clade A/G. Pediatr Infect Dis J 2005;24:183-184.
9. Ling AE, Robbins KE, Brown TM, et al.: Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period. JAMA 2000;284:210-214.
10. O'Shea S, Chrystie I, Cranston R, et al.: Problems in the interpretation of HIV-1 viral load assays using commercial reagents. J Med Virol 2000;61:187-194.
11. Debyser Z, Van Wijngaerden E, Van Laethem K, et al.: Failure to quantify viral load with two of the three commercial methods in a pregnant woman harboring an HIV type 1 subtype G strain. AIDS Res Hum Retroviruses 1998;14:453-459.
12. Arnold C, Barlow KL, Kaye S, Loveday C, Balfe P, Clewley JP: HIV type 1 sequence subtype G transmission from mother to infant: failure of variant sequence species to amplify in the Roche Amplicor Test. AIDS Res Hum Retroviruses 1995;11:999-1001.
13. Gottesman BS, Grosman Z, Lorber M, et al.: Measurement of HIV RNA in patients infected by subtype C by assays optimized for subtype B results in an underestimation of the viral load. J Med Virol 2004;73:167-171.
14. Amendola A, Bordi L, Angeletti C, et al.: Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02). J Acquir Immune Defic Syndr 2002;31:488-494.
15. Triques K, Coste J, Perret JL, et al.: Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1. J Clin Microbiol 1999;37:110-116.
16. Malmsten A, Shao XW, Aperia K, et al.: HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. J Med Virol 2003;71:347-359.
17. Greengrass VL, Turnbull SP, Hocking J, et al.: Evaluation of a low cost reverse transcriptase assay for plasma HIV-1 viral load monitoring. Curr HIV Res 2005;3:183-190.
18. Braun J, Plantier JC, Hellot MF, et al.: A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes. AIDS 2003;17:331-336.
19. Malmsten A, Shao XW, Sjodahl S, et al.: Improved HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. J Med Virol 2005;76:291-296.
20. Sivapalasingam S, Essajee S, Nyambi PN, et al.: Human immunodeficiency virus (HIV) reverse transcriptase activity correlates with HIV RNA load: implications for resource-limited settings. J Clin Microbiol 2005;43:3793-3796.
21. Corrigan GE, Al-Khalili L, Malmsten A, et al.: Differences in reverse transcriptase activity versus p24 antigen detection in cell culture, when comparing a homogeneous group of HIV type 1 sub-type B viruses with a heterogeneous group of divergent strains. AIDS Res Hum Retroviruses 1998;14:347-352.
22. Ten Haaft P, Verstrepen B, Uberla K, Rosenwirth B, Heeney J: A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques. J Virol 1998;72:10281-10285.
23. Clarke S, Almond N, Berry N: Simian immunodeficiency virus Nef gene regulates the production of 2-LTR circles in vivo. Virology 2003;306:100-108.
24. Israel-Ballard K, Chantry C, Dewey K, et al.: Viral, nutritional, and bacterial safety of Hash-heated and pretoria-pasteurized breast milk to prevent mother-to-child transmission of HIV in resource-poor countries: A pilot study. J Acquir Immune Defic Syndr 2005;40:175-181.